All studies
Pediatric and FamilyPhase IIIEnrolling Soon
Investigational Therapy for Pediatric Moderate Persistent Asthma
Assessing the safety and asthma control of an investigational add-on therapy in children with moderate persistent asthma despite standard controller medication.
Time commitment
52 weeks
Compensation
Up to $1,500
Site
PRIME Trials — Downtown
Who may qualify
Children 6–17 with moderate persistent asthma on a stable inhaled corticosteroid.
Step 1 of 1
Enroll in this study
Answer a few quick questions below and a study coordinator will call you to confirm eligibility. It takes about a minute and there is no obligation.
Start Enrollment
Investigational Therapy for Pediatric Moderate Persistent Asthma
Step 1 of 4Takes ~1 minute
Enter your ZIP code so we can match you to the nearest site.
Prefer to talk now?
Call or text our team and we will walk you through this study.
